SCHEMBL19202522

SCHEMBL19202522

CCC(C(=O)O)c1ccc2sc3ccccc3c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
AKR1C3 P42330 5/20 0.43
AKR1C2 P52895 5/20 0.43
AKR1C1 Q04828 1/20 0.43
PTGS1 P23219 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HCRTR1 O43613 2/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31256676 0.82 AKR1B1 (0.58) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL12726877 0.82 AKR1B1 (0.58) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL10997509 0.81 KDM4E (0.53) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL11046600 0.81 KDM4E (0.53) MAPTALDH1A1KDM4ENPC1RAB9A
Benzophenone SCHEMBL28091178 0.79 MAPT (0.48) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL19202609 0.78 ALDH1A1 (0.50) MAPTALDH1A1KDM4ENPC1RAB9A
Acetone SCHEMBL28555705 0.78 KDM4E (0.53) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL30612323 0.77 KDM4E (0.58) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL29353401 0.77 KDM4E (0.58) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL41594 0.77 KDM4E (0.58) MAPTALDH1A1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548984-B2 Light- or heat-curing method and curable resin composition FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2023-01-10 US disclosed
US-10774062-B2 Photocuring method, compound and composition used therein FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-09-15 US disclosed
EP-3409709-B1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-08-19 EP disclosed
US-20200123324-A1 LIGHT- OR HEAT-CURING METHOD AND CURABLE RESIN COMPOSITION FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-04-23 US disclosed
US-20190055210-A1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-02-21 US disclosed
WO-2017131047-A1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN 和光純薬工業株式会社 2017-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055210-A1 PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN ESD, TMT1A, PAM MAPT 2301/4885ALDH1A1 23/4885KDM4E 1162/4885
US-10774062-B2 Photocuring method, compound and composition used therein ESD, TMT1A, PAM MAPT 2301/4885ALDH1A1 23/4885KDM4E 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.